NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Guangzhou Sinogen Pharmaceutical Co., Ltd.

Guangzhou Sinogen Pharmaceutical Co., Ltd.

Private
GuangzhouHealthcare & Life Scienceshttps://huajinpharmtech.com/

Last Round

Series B

Dec 1, 2023

Company Overview

Guangzhou Sinogen Pharmaceutical Co., Ltd. is a biotechnology company that focuses on the research, development, and production of innovative biological oncology drugs, specifically tumor-targeting oncolytic bacteria.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

oncolytic bacteriaoncolytic viruscancer immunotherapysolid tumor treatmentbiotech R&Ddrug discoveryclinical trialspreclinical evaluationgenetic engineeringbioinformaticsonco-immunologydrug licensingGMP manufacturingprecision medicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Guangzhou Sinogen Pharmaceutical Co., Ltd. Comparables

Compare Guangzhou Sinogen Pharmaceutical Co., Ltd. with similar companies based on industry and business-model similarity.

Guangzhou Sinogen Pharmaceutical Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Shaoxing Salvectors Biotechnology Ltd.
84%
TILT Biotherapeutics
83%
BioMed Valley Discoveries
80%

Guangzhou Sinogen Pharmaceutical Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BDec 1, 2023
VC RoundMay 1, 2022
Series ASep 1, 2020
AngelSep 1, 2017

Guangzhou Sinogen Pharmaceutical Co., Ltd. Investors

Notable investors and investment history

Guangzhou Sinogen Pharmaceutical Co., Ltd. investors
InvestorRounds
Zhejiang Sino Wisdom Investment ManagementVC Round
河北沿海产业投资基金管理有限公司Series B
CICC CapitalSeries A
Winzac Capital ManagementSeries A
Share CapitalAngel

Guangzhou Sinogen Pharmaceutical Co., Ltd. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Guangzhou Sinogen Pharmaceutical Co., Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Guangzhou Sinogen Pharmaceutical Co., Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersGuangzhou
Year Founded2016
Last FundingDec 1, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.